Skip to content
Fintech & Funding

Cohere And Aleph Alpha Sign Their Merger: A ~$20bn Transatlantic 'Sovereign AI' Bet, And What It Means For UK Financial Firms Choosing A Model Provider

On 16 September Cohere and Aleph Alpha signed a definitive agreement to combine, formalising a deal first disclosed in April. The combined company - reported at roughly $20bn - will operate as Cohere, dual-headquartered in Berlin and Toronto with Heidelberg kept as a research centre, and pitches itself as the first transatlantic sovereign AI provider for government, finance, defence and other regulated sectors. Germany's Schwarz Group is committing about $600m (€500m) as lead investor in Cohere's Series E. The deal still needs regulatory approval and is expected to close later this year. As the leading US labs move in lockstep on pace and face antitrust scrutiny for it, the case for a credible non-US option has rarely been clearer - and Britain needs to decide where it stands.

AlchmAI Editorial11 min read

16 Sept

Cohere and Aleph Alpha signed a definitive business combination agreement, formalising the April 2026 announcement

~$20bn

Reported valuation of the combined company, which will operate globally as Cohere

€500m

Around $600m committed by Germany's Schwarz Group as lead investor in Cohere's Series E

1,000+

Expected employees across Berlin, Toronto and a retained Heidelberg research centre

European AI has spent three years arguing about whether it can compete with the US frontier labs. Cohere and Aleph Alpha have made an argument by structure instead. On 16 September the two signed a definitive business combination agreement, formalising a plan first disclosed on 24 April. The combined company will operate globally as Cohere, dual-headquartered in Berlin and Toronto, with Aleph Alpha's Heidelberg office retained as a research centre. Aleph Alpha's co-CEO Ilhan Scheer becomes chief operating officer and co-founder Samuel Weinbach chief research officer on closing. Germany's Schwarz Group - owner of Lidl and Kaufland and a major cloud provider through its IT arm - is committing about $600m (€500m) as lead investor in Cohere's Series E. The deal is reported at roughly $20bn and is expected to close later in 2026, subject to regulatory approval.

The pitch is explicit: the first transatlantic sovereign AI solution, and the first foundation-model developer anchored on both sides of the Atlantic, built to meet the sovereignty requirements of Canada and Germany. Target sectors are the regulated ones - public sector, finance, defence, energy, manufacturing, telecoms and healthcare. Cohere's chief executive Aidan Gomez put it in a sentence aimed squarely at those buyers: no government or enterprise should have to choose between capable AI and control.

Why The Timing Matters

  • Provider concentration has become visible. When Anthropic, OpenAI, Google and SpaceXAI moved together on 12 September, the risk of depending on a handful of US providers stopped being theoretical. The Bank of England had already flagged AI-provider concentration as a stability concern.
  • Regulated buyers want private deployment. Banks and insurers increasingly run models inside their own cloud or data centre for sensitive workloads. Cohere has built its enterprise business around private deployment, and Aleph Alpha around public-sector and on-premise use.
  • Europe's AI Act is in force for high-risk systems. From 2 August 2026, EU obligations on documentation, oversight and data governance apply to high-risk uses such as credit scoring. A provider built for European compliance is a practical advantage for firms serving EU customers.
  • Capital is concentrating. With AI taking the large majority of venture funding, scale matters. Combining two second-tier players into one well-funded one is a rational response to a market where mid-sized model makers struggle to raise.

“No government or enterprise should have to choose between capable AI and control. - Aidan Gomez, Cohere”

Where This Leaves Britain

We will state our bias: we are a London firm and we think Britain should be at the centre of this, not a customer of it. The UK has world-class AI research, the deepest financial-services market in Europe and a £500m Sovereign AI Unit launched in April to invest in UK AI companies and provide compute. What it lacks is a scaled, home-grown foundation-model company in the Cohere mould. A Berlin-Toronto axis for sovereign AI, with a German industrial group as anchor investor, is a reminder that other countries are acting on sovereignty while Britain is still defining it. The Sovereign AI Unit's best use may be to ensure a UK anchor in exactly this kind of transatlantic arrangement - and the UK's flexible regulatory posture makes London the natural place to host it.

The Bottom Line

Cohere and Aleph Alpha's definitive agreement, signed on 16 September and reported at about $20bn with around €500m from Schwarz Group, creates a transatlantic sovereign AI provider aimed squarely at regulated industries including finance. Its timing - the month the US labs moved in lockstep on pace and were sued for it - makes the case for credible alternatives stronger than it has been. For UK banks and insurers, the practical response is multi-provider architecture, private deployment where the data demands it, and documented exit plans. For Britain, it is a prompt to make sure the next sovereign AI champion has a London anchor. As a fintech AI agency in London we design systems that can run on any credible provider - and this week added a serious one to the list.

References & Further Reading

Fintech AI Agency Londonsovereign AICohereAleph AlphaAI Agency UKEnterprise-Grade Security & ScalabilityAI funding
Share Email
AI

AlchmAI Editorial

Research and analysis, London

The AlchmAI team writes about the markets, technology and regulation we work with every day. We build trading platforms, real-time charts and AI analysis tools for brokers, prop firms and fintech teams from our office in Mayfair, London. Every article lists its sources. Nothing we publish is investment advice.

This article is general information and commentary. It is not investment advice or a recommendation to buy or sell any investment. Important information

Keep reading

All articles